BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

720 related articles for article (PubMed ID: 22342771)

  • 1. Strategies for controlled delivery of growth factors and cells for bone regeneration.
    Vo TN; Kasper FK; Mikos AG
    Adv Drug Deliv Rev; 2012 Sep; 64(12):1292-309. PubMed ID: 22342771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Matrices and scaffolds for delivery of bioactive molecules in bone and cartilage tissue engineering.
    Lee SH; Shin H
    Adv Drug Deliv Rev; 2007 May; 59(4-5):339-59. PubMed ID: 17499384
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advances in Growth Factor Delivery for Bone Tissue Engineering.
    Oliveira ÉR; Nie L; Podstawczyk D; Allahbakhsh A; Ratnayake J; Brasil DL; Shavandi A
    Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33477502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biomaterial delivery of morphogens to mimic the natural healing cascade in bone.
    Mehta M; Schmidt-Bleek K; Duda GN; Mooney DJ
    Adv Drug Deliv Rev; 2012 Sep; 64(12):1257-76. PubMed ID: 22626978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Growth Factor and Its Polymer Scaffold-Based Delivery System for Cartilage Tissue Engineering.
    Chen L; Liu J; Guan M; Zhou T; Duan X; Xiang Z
    Int J Nanomedicine; 2020; 15():6097-6111. PubMed ID: 32884266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A biomimetic growth factor delivery strategy for enhanced regeneration of iliac crest defects.
    Huri PY; Huri G; Yasar U; Ucar Y; Dikmen N; Hasirci N; Hasirci V
    Biomed Mater; 2013 Aug; 8(4):045009. PubMed ID: 23782488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Osteogenic potential of the growth factors and bioactive molecules in bone regeneration.
    Safari B; Davaran S; Aghanejad A
    Int J Biol Macromol; 2021 Apr; 175():544-557. PubMed ID: 33571587
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth factor delivery: how surface interactions modulate release in vitro and in vivo.
    King WJ; Krebsbach PH
    Adv Drug Deliv Rev; 2012 Sep; 64(12):1239-56. PubMed ID: 22433783
    [TBL] [Abstract][Full Text] [Related]  

  • 9. From nano- to macro-scale: nanotechnology approaches for spatially controlled delivery of bioactive factors for bone and cartilage engineering.
    Santo VE; Gomes ME; Mano JF; Reis RL
    Nanomedicine (Lond); 2012 Jul; 7(7):1045-66. PubMed ID: 22846091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spatial regulation of controlled bioactive factor delivery for bone tissue engineering.
    Samorezov JE; Alsberg E
    Adv Drug Deliv Rev; 2015 Apr; 84():45-67. PubMed ID: 25445719
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bioengineering strategies for bone and cartilage tissue regeneration using growth factors and stem cells.
    Qasim M; Chae DS; Lee NY
    J Biomed Mater Res A; 2020 Mar; 108(3):394-411. PubMed ID: 31618509
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Local and targeted drug delivery for bone regeneration.
    Newman MR; Benoit DS
    Curr Opin Biotechnol; 2016 Aug; 40():125-132. PubMed ID: 27064433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immobilization and Application of Electrospun Nanofiber Scaffold-based Growth Factor in Bone Tissue Engineering.
    Chen G; Lv Y
    Curr Pharm Des; 2015; 21(15):1967-78. PubMed ID: 25732663
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic-designed electrospun bone scaffolds: mesoporous bioactive nanocarriers in hollow fiber composites to sequentially deliver dual growth factors.
    Kang MS; Kim JH; Singh RK; Jang JH; Kim HW
    Acta Biomater; 2015 Apr; 16():103-16. PubMed ID: 25617805
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surface engineered and drug releasing pre-fabricated scaffolds for tissue engineering.
    Chung HJ; Park TG
    Adv Drug Deliv Rev; 2007 May; 59(4-5):249-62. PubMed ID: 17482310
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential of endogenous regenerative technology for in situ regenerative medicine.
    Anitua E; Sánchez M; Orive G
    Adv Drug Deliv Rev; 2010 Jun; 62(7-8):741-52. PubMed ID: 20102730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Temporally controlled multiple-gene delivery in scaffolds: A promising strategy to enhance bone regeneration.
    Liu J; Xu L; Li Y; Ma J
    Med Hypotheses; 2011 Feb; 76(2):173-5. PubMed ID: 20926199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decellularized bone extracellular matrix in skeletal tissue engineering.
    Rothrauff BB; Tuan RS
    Biochem Soc Trans; 2020 Jun; 48(3):755-764. PubMed ID: 32369551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The scope and sequence of growth factor delivery for vascularized bone tissue regeneration.
    Bayer EA; Gottardi R; Fedorchak MV; Little SR
    J Control Release; 2015 Dec; 219():129-140. PubMed ID: 26264834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Growth Factor Delivery Using a Collagen Membrane for Bone Tissue Regeneration.
    Takayama T; Imamura K; Yamano S
    Biomolecules; 2023 May; 13(5):. PubMed ID: 37238679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.